Back
Regeneron Pharmaceuticals Vs. Expedia Group Industry Stock Comparison
Buy
65
REGN
Regeneron Pharmaceuticals
Last Price:
982.60
Seasonality Move:
8.1%
Sell
48
EXPE
Expedia Group
Last Price:
113.98
Seasonality Move:
8.66%
Buy
65
Regeneron Pharmaceuticals (REGN)
is a Buy
Is Regeneron Pharmaceuticals a Buy, Sell or Hold?
- The current Regeneron Pharmaceuticals [REGN] share price is $982.29. The Score for REGN is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- REGN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
Expedia Group (EXPE)
is a Sell
Is Expedia Group a Buy, Sell or Hold?
- The current Expedia Group [EXPE] share price is $114.01. The Score for EXPE is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- EXPE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
REGN Stock Price Chart
What is Regeneron Pharmaceuticals's stock price today?
-
The Regeneron Pharmaceuticals share price today is $982.29
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REGN is experiencing buying pressure, which is a positive indicator for future bullish movement.
EXPE Stock Price Chart
What is Expedia Group's stock price today?
-
The Expedia Group share price today is $114.01
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EXPE is experiencing slight buying pressure.
REGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 14.5 | Buy |
| Relative Strength Index (14 RSI): | 64.04 | Buy |
| Chaikin Money Flow: | 364335 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (893.96 - 967.54) | Buy |
| Bollinger Bands (100): | (910.83 - 972.27) | Buy |
EXPE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -5.51 | Sell |
| Relative Strength Index (14 RSI): | 32.68 | Sell |
| Chaikin Money Flow: | 1004127 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (114.28 - 134.18) | Sell |
| Bollinger Bands (100): | (125.67 - 148.45) | Sell |
REGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 973.46 | Buy |
| 20-day SMA: | 939.22 | Buy |
| 50-day SMA: | 942.8 | Buy |
| 200-day SMA: | 880.68 | Buy |
| 8-day EMA: | 970.66 | Buy |
| 20-day EMA: | 952.53 | Buy |
| 50-day EMA: | 942.21 | Buy |
| 200-day EMA: | 886.86 | Buy |
EXPE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 112.87 | Buy |
| 20-day SMA: | 123.1 | Sell |
| 50-day SMA: | 129.38 | Sell |
| 200-day SMA: | 125.89 | Sell |
| 8-day EMA: | 114.63 | Sell |
| 20-day EMA: | 120.08 | Sell |
| 50-day EMA: | 127.21 | Sell |
| 200-day EMA: | 126.93 | Sell |
Regeneron Pharmaceuticals Earnings Growth & REGN Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.08 per share, a decrease next quarter of $0.30 per share, an increase this year of $1.59 per share, and an increase next year of $3.24 per share.
Expedia Group Earnings Growth & EXPE Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.46 per share, a decrease next quarter of $2.62 per share, an increase this year of $2.12 per share, and an increase next year of $2.83 per share.
Regeneron Pharmaceuticals Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Expedia Group Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||